Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rafael Holdings Inc (NY: RFL ) 1.440 -0.010 (-0.70%) Streaming Delayed Price Updated: 3:54 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 22,015 Open 1.430 Bid (Size) 1.420 (20) Ask (Size) 1.440 (2) Prev. Close 1.450 Today's Range 1.420 - 1.456 52wk Range 1.410 - 2.520 Shares Outstanding 100 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News RFL Stock Earnings: Rafael Holdings Reported Results for Q3 2024 June 14, 2024 Rafael Holdings just reported results for the third quarter of 2024. Via InvestorPlace Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results June 14, 2024 Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential From Rafael Holdings, Inc. Via GlobeNewswire Performance YTD -21.32% -21.32% 1 Month -2.05% -2.05% 3 Month -16.77% -16.77% 6 Month -24.22% -24.22% 1 Year -30.10% -30.10% More News Read More Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1 May 30, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results March 13, 2024 From Rafael Holdings, Inc. Via GlobeNewswire RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024 December 14, 2023 Via InvestorPlace Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results December 14, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Reports Third Quarter 2023 Financial Results November 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results October 30, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Reports Second Quarter 2023 Financial Results August 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc. August 02, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update June 13, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement June 05, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results May 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) May 02, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 26, 2023 Via InvestorPlace Rafael Holdings Announces up to $5 Million Share Repurchase Program April 04, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results March 14, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Top Real Estate Stocks That May Plunge February 17, 2023 Via Benzinga Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results December 13, 2022 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities November 15, 2022 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results October 31, 2022 From Rafael Holdings, Inc. Via GlobeNewswire Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer September 28, 2022 From Cornerstone Pharmaceuticals Via GlobeNewswire Alibaba, Zoom Video And 76 Biggest Movers From Yesterday July 12, 2022 Via Benzinga Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session July 11, 2022 Via Benzinga More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying July 08, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
